Patents Examined by Young J. Kim
  • Patent number: 11193872
    Abstract: A method of aligning a plurality of targets is provided. The method includes generating a plurality of targets. A third phase includes the plurality of targets. The method further includes combining a first phase, a second phase, and the third phase in a volume. The first phase, the second phase, and the third phase are substantially immiscible, and the third phase is in fluid communication with the first phase and the second phase, and the first phase, the second phase, and the third phase are operable to be in a configuration of the third phase between the first phase and the second phase in the volume.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: December 7, 2021
    Assignee: Life Technologies Corporation
    Inventors: Mark Andersen, Michael Pallas, Haopeng Wang
  • Patent number: 11193167
    Abstract: Multiplex pyrophosphorolysis activated polymerization uses multiple pairs of blocked primers to amplify multiple potential templates in a single reaction, including those almost-sequence-identical templates located in one locus. To identify and differentiate the multiple amplified products, individual molecules are sequenced in parallel. Thus multiplex PAP amplification is combined with parallel sequencing for ultrahigh-sensitive, ultrahigh-selective and ultrahigh-throughput detection of early cancer.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: December 7, 2021
    Inventors: Shaofeng Ding, Qiang Liu
  • Patent number: 11186862
    Abstract: Improved multiple displacement amplification (MDA) reagents and methods are provided.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: November 30, 2021
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Ronald Lebofsky, Jeremy Agresti, George Karlin-Neumann
  • Patent number: 11180815
    Abstract: This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: November 23, 2021
    Assignee: PACIFIC EDGE LIMITED
    Inventors: Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Yu-Hsin Lin, Robert Craig Pollock
  • Patent number: 11180798
    Abstract: A method of nucleic acid amplification involving using a first modified primer which provides protection to the amplification product from exonuclease degradation and a second primer. The method provides a double stranded nucleic acid, one strand of which is degraded by a double strand nucleic acid specific exonuclease to form a single stranded nucleic acid, which is protected from exonuclease degradation.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: November 23, 2021
    Assignee: Binx Health Limited
    Inventors: Daniel Adlerstein, David M. Pearce, Anna Dixon, Wellington Fakanya
  • Patent number: 11173490
    Abstract: The present disclosure relates to a sample assessment device. By way of example, the sample assessment device may include a substrate including a sample application region; an amplification region comprising a plurality of amplification reagents; a waste region comprising an entrance fluidically coupled to the amplification region and extending away from the amplification region; and a detection region spaced apart from the amplification region. The sample assessment device may also include a valve coupled to the substrate and configured to separate the amplification region from the detection region in a closed configuration, wherein the amplification region and the valve are positioned on the sample assessment device between the sample application region and the detection region and wherein the sample assessment device is configured to permit lateral flow from the amplification region to the detection region when the valve is in an open configuration.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: November 16, 2021
    Assignees: University of Washington, Global Life Sciences Solutions Operations UK Ltd.
    Inventors: David Roger Moore, Matthew Jeremiah Misner, Andrew Arthur Paul Burns, Joshua Bishop, Lisa K. Lafleur, Maxwell Wheeler
  • Patent number: 11162094
    Abstract: A nucleic acid patch method for amplifying target nucleic acid sequences in circulating free DNA or residual DNA samples where the defining ends of the target nucleic acid sequences are unknown.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: November 2, 2021
    Assignee: KAILOS GENETICS, INC.
    Inventors: Katherine E. Varley, D. Troy Moore, Randall Bachmeyer, David Kloske
  • Patent number: 11155886
    Abstract: Methods for the rapid detection of the presence or absence of Zika virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting Zika virus and kits are provided that are designed for the detection of Zika virus.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: October 26, 2021
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Slav Dugenny, Ellen H Fiss, Jeffery Fong, Marintha Heil, Eugene Spier, Jingtao Sun
  • Patent number: 11142785
    Abstract: The present technology provides for an apparatus for detecting polynucleotides in samples, particularly from biological samples. The technology more particularly relates to microfluidic systems that carry out PCR on nucleotides of interest within microfluidic channels, and detect those nucleotides. The apparatus includes a microfluidic cartridge that is configured to accept a plurality of samples, and which can carry out PCR on each sample individually, or a group of, or all of the plurality of samples simultaneously.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: October 12, 2021
    Assignee: HandyLab, Inc.
    Inventors: Kalyan Handique, Sundaresh N. Brahmasandra, Karthik Ganesan, Jeff Williams
  • Patent number: 11136620
    Abstract: The invention features a fully-integrated rapid molecular diagnostic device that is low-cost, easy to manufacture, and simple to use. The device can serve as a molecular diagnostic platform for any disease, requiring little or no preparation or customization and can be made from simple materials (e.g., paper and adhesive film), making it inexpensive, portable, and disposable. The invention also provides methods of using the device for detection of one or more targets in a sample.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: October 5, 2021
    Assignee: Trustees of Boston University
    Inventors: Catherine M. Klapperich, Natalia M. Rodriguez, Jacqueline C. Linnes
  • Patent number: 11130984
    Abstract: The present invention provides methods, compositions, kits, systems and apparatus that are useful for isolating nucleic acid molecules from a sample. In particular, the methods generally relate to normalizing the concentration of target nucleic acid molecules from a sample. In one aspect, the invention relates to purifying a primer extension product from a primer extension reaction mixture. In some aspects, nucleic acid molecules obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: September 28, 2021
    Assignee: Life Technologies Corporation
    Inventors: Mark Andersen, Steven Roman
  • Patent number: 11124844
    Abstract: A region of the Trichomonas vaginalis AP65-1 gene has been identified which is useful for performing amplification assays to determine specifically whether T. vaginalis is present in the sample being tested. Oligonucleotides useful for performing thermal Strand Displacement Assay (tSDA) reactions on this gene are disclosed. The disclosed oligonucleotides can be used in an assay which is specific for multiple strains of T. vaginalis and which does not show cross reactivity with the genomes of other microorganisms or with human DNA.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: September 21, 2021
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventor: Ray A. McMillian
  • Patent number: 11111524
    Abstract: Described herein, among other things, is a method of sequencing, comprising: concatenating a plurality of fragments of genomic DNA to produce concatenated DNA; sequencing the concatenated DNA to produce a plurality of sequence reads, wherein at least some of the sequence reads comprise: at least the sequence of the 3? and/or 5? ends of a fragment that corresponds to the locus of interest and sequence of one or both of the fragments that flank the fragment in the concatenated DNA; and grouping the sequence reads that corresponds to the locus of interest using, for each of the grouped sequence reads: the 3? and/or 5? end sequences; and/or the flanking sequence.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: September 7, 2021
    Assignee: OXFORD NANOPORE TECHNOLOGIES, LTD.
    Inventors: Robert Osborne, Esther Musgrave-Brown
  • Patent number: 11111527
    Abstract: Provided for herein is a method for detecting the presence of a nucleic acid target molecule in a biological sample. In certain aspects, the method comprises contacting a test sample that comprises (i) a biological sample comprising a nucleic acid target molecule and (ii) an osmylated single-stranded oligonucleotide probe comprising at least one pyrimidine residue covalently bonded to a substituted or unsubstituted Osmium tetroxide (OsO4)-2,2?-bypyridine group (OsBp group).
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: September 7, 2021
    Inventor: Anastassia Kanavarioti
  • Patent number: 11104895
    Abstract: Described herein are methods and means for reliably releasing maternal and/or paternal DNA from single seeds without substantially affecting the subsequent germination of the seeds. The methods are particularly suited for genome analysis of small grain cereals, including wheat. The methods may include enzymatic treatments for improved DNA recovery.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: August 31, 2021
    Assignee: BASF SE
    Inventors: Kristof Van der Meeren, Rainhard Koch, Philipp Ellinger, Nina Jansen, Stephen Rae, Martin Clausen
  • Patent number: 11091801
    Abstract: A composition comprising a thermostable DNA polymerase; and a PCR inhibitor blocking agent, wherein the PCR inhibitor blocking agent is present in an amount effective to enhance tolerance of an assembled PCR to a PCR inhibitor.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: August 17, 2021
    Assignee: Life Technologies Corporation
    Inventors: Christopher Trinh, Tom Xu, Yating Shi, Ferrier Le, Claire Marjoribanks
  • Patent number: 11091805
    Abstract: The invention relates to a process for analysing single molecules, in particular for sequencing of single nucleic acid molecules.
    Type: Grant
    Filed: January 5, 2015
    Date of Patent: August 17, 2021
    Assignee: Gnothis Holding AG
    Inventors: Rudolf Rigler, Lars Edman
  • Patent number: 11090649
    Abstract: The present invention relates to a low-cost, thermally reversible valve for paper-fluidic diagnostic devices. In particular, this invention demonstrates a tunable valve mechanism fabricated by wax-ink printing and localized heating via thin-film resistors to sequentially release liquids through a cellulose or nitrocellulose membrane. The wax-ink valve can obstruct fluid flow for a sustained time and are thermally actuated to release a controlled amount of liquid past the valve. This integrated paper-fluidic diagnostic assay device requires minimal user involvement, can be easily manufactured and tuned to meet various fluid delivery timing and incubation needs.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: August 17, 2021
    Assignee: Purdue Research Foundation
    Inventors: Jacqueline C Linnes, Megan Zaiyi Chiu, Rui Shen
  • Patent number: 11085069
    Abstract: The present technology provides for an apparatus for detecting polynucleotides in samples, particularly from biological samples. The technology more particularly relates to microfluidic systems that carry out PCR on nucleotides of interest within microfluidic channels, and detect those nucleotides. The apparatus includes a microfluidic cartridge that is configured to accept a plurality of samples, and which can carry out PCR on each sample individually, or a group of, or all of the plurality of samples simultaneously.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: August 10, 2021
    Assignee: HandyLab, Inc.
    Inventors: Kalyan Handique, Sundaresh N. Brahmasandra, Karthik Ganesan, Jeff Williams
  • Patent number: 11072789
    Abstract: Methods and apparatus of some aspects of the invention relate to the synthesis of high fidelity polynucleotides. In particular, aspects of the invention relate to concurrent enzymatic removal of amplification sequences and ligation of processed oligonucleotides into nucleic acid assemblies. According to some embodiments, the invention provides a method for producing a target nucleic acid having a predefined sequence. In some embodiments, the method comprises the step of providing a plurality of oligonucleotides, wherein each oligonucleotides comprises (i) an internal sequence identical to a different portion of a sequence of a target nucleic acid, (ii) a 5? sequence flanking the 5? end of the internal sequence and a 3? flanking sequence flanking the 3? end of the internal sequence, each of the flanking sequence comprising a primer recognition site for a primer pair and a restriction enzyme recognition site.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: July 27, 2021
    Assignee: Gen9, Inc.
    Inventors: Michael E. Hudson, Li-Yun A. Kung, Daniel Schindler, Stephen Archer, Ishtiaq Saaem